Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belinostat + Chemotherapy in Advanced Thymic Malignancies
NCT01100944Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Mar 2010
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belinostat in thymoma, thymic carcinoma (TC), sponsored by National Cancer Institute. Started Mar 2010; status: terminated.
02
Drugs
belinostat
03
Conditions
thymomathymic carcinoma (TC)
Beyond the preview
Go deeper on NCT01100944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100944.